Amarin Corp Plc (AMRN)

[ranjo]

DS industry is not going to go away without a long protracted battle.. way too much money at stake. The narrative will be how once again the government/FDA gets involved and the consumer ends up subsidizing BP's bottom line. Purity, therapeutic dosing and the reduce it study will have to be widely publicized to educate the masses. At present, public opinion is we should be doing more to lower pharmaceutical costs so much educating will be necessary if indeed the itc and fda support NCE and out comes studies. The facts are even in some lower doses of not so pure EPA certain populations benefit is a meaningful way; what needs to be communicated is the same is true in ibuprofen but lets be clear on the indication and not one shoe fits all sizes. The pleotropic effects of EPA is going to be the focus of many researchers in the years to come.